Semi-interpenetrating network (sIPN) gelatin nanofiber scaffolds for oral mucosal drug delivery
Source abstract
Abstract
The oral mucosa is a promising absorption site for drug administration because it is permeable, highly vascularized and allows for ease of administration. Nanofiber scaffolds for local or systemic drug delivery through the oral mucosa, however, have not been fully explored. In this work, we fabricated electrospun gelatin nanofiber scaffolds for oral mucosal drug delivery. To improve structural stability of the electrospun gelatin scaffolds and allow non-invasive incorporation of therapeutics into the scaffold, we employed photo-reactive polyethylene glycol diacrylate (PEG-DA575, 575 gmol(-1)) as a cross-linker to stabilize the scaffold by forming semi-interpenetrating network gelatin nanofiber scaffolds (sIPN NSs), during which cross-linker concentration was varied (1×, 2×, 4× and 8×). The results showed that electrospun gelatin nanofiber scaffolds after being cross-linked with PEG-DA575 (i.e. sIPN NS1×, 2×, 4× and 8×) retained fiber morphology and possessed improved structural stability. A series of structural parameters and properties of the cross-linked electrospun gelatin scaffolds were systematically characterized in terms of morphology, fiber diameter, mechanical properties, porosity, swelling and degradation. Mucin absorption onto sIPN NS4× was also confirmed, indicating this scaffold possessed greatest mucoadhesion properties among those tested. Slow release of nystatin, an anti-fungal reagent, from the sIPN gelatin nanofiber scaffold was demonstrated.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Nerve injury and regeneration
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. Local drug delivery for oral mucosal diseases: challenges and opportunities10.1111/j.1601-0825.2011.01793.x ↗
2. Buccal mucosa as a route for systemic drug delivery: a review
3. Developments in buccal drug delivery
4. New developments and opportunities in oral mucosal drug delivery for local and systemic disease10.1016/j.addr.2011.02.008 ↗
5. Buccal bioadhesive drug delivery – a promising option for orally less efficient drugs10.1016/j.jconrel.2006.04.012 ↗
6. Bioadhesive films containing benzocaine: correlation between in vitro permeation and in vivo local anesthetic effect10.1007/s11095-010-0151-5 ↗
7. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery10.1016/S0168-3659(98)00044-3 ↗
8. Oral candidiasis: pathogenesis and host defense10.1093/clinids/6.1.96 ↗
9. Oral mucosal fungal infections10.1111/j.1600-0757.2008.00291.x ↗
10. Electrospinning of collagen nanofibers10.1021/bm015533u ↗
11. Electrospinning collagen and elastin: preliminary vascular tissue engineering10.2741/1313 ↗
12. Cross-linking electrospun type II collagen tissue engineering scaffolds with carbodiimide in ethanol10.1089/ten.2006.0292 ↗
13. Nanofiber-based delivery of bioactive agents and stem cells to bone sites10.1016/j.addr.2012.04.008 ↗
14. Nanofibrous tissue engineering scaffolds capable of growth factor delivery10.1007/s11095-011-0367-z ↗
15. Nanostructured biomaterials for regeneration10.1002/adfm.200800662 ↗
16. Electrospinning: applications in drug delivery and tissue engineering10.1016/j.biomaterials.2008.01.011 ↗
17. Nanofiber technology: designing the next generation of tissue engineering scaffolds10.1016/j.addr.2007.04.022 ↗
18. Synthesis and physicochemical analysis of interpenetrating networks containing modified gelatin and poly(ethylene glycol) diacrylate10.1002/jbm.a.10106 ↗
19. Drug release kinetics and transport mechanisms from semi-interpenetrating networks of gelatin and poly(ethylene glycol) diacrylate10.1007/s11095-009-9923-1 ↗
20. Tuning electrospinning parameters for production of 3D-fiber-fleeces with increased porosity for soft tissue engineering applications10.22203/eCM.v021a22 ↗
21. Cross-linking methods of electrospun fibrinogen scaffolds for tissue engineering applications10.1088/1748-6041/3/4/045001 ↗
22. Fabrication of poly(alpha-hydroxy acid) foam scaffolds using multiple solvent systems10.1002/jbm.1269 ↗
23. Monitoring of drug concentrations in saliva: a non-invasive pharmacokinetic procedure
24. High-performance liquid chromatographic determination of liposomal nystatin in plasma and tissues for pharmacokinetic and tissue distribution studies10.1016/S0378-4347(99)00396-5 ↗
25. Scaffold permeability as a means to determine fiber diameter and pore size of electrospun fibrinogen10.1002/jbm.a.31556 ↗
26. Phase separation, pore structure, and properties of nanofibrous gelatin scaffolds10.1016/j.biomaterials.2009.04.024 ↗
27. Electrospinning of gelatin fibers and gelatin/PCL composite fibrous scaffolds10.1002/jbm.b.30128 ↗
28. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems10.1016/j.addr.2005.07.008 ↗
29. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues10.1016/0168-3659(85)90050-1 ↗
30. Role of salivary mucins in the protection of the oral cavity10.1111/j.1600-0714.1982.tb00138.x ↗
31. The oral cavity as a site for systemic drug-delivery10.1016/0169-409X(94)90024-8 ↗
32. Oral cavity as a site for bioadhesive drug delivery10.1016/0169-409X(94)90026-4 ↗
33. The influence of elastin-like recombinant polymer on the self-renewing potential of a 3D tissue equivalent derived from human lamina propria fibroblasts and oral epithelial cells10.1016/j.biomaterials.2011.04.054 ↗
34. Drug transfer through mucus10.1016/S0169-409X(01)00115-6 ↗